MedTrace Logo

Understanding Factors in Decision Making for Children With Medical Complexity

NCT05913206 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 831

Last updated 2026-02-24

Study results available
· View outcomes & findings →

Summary

The goal of this clinical trial is to compare different strategies to communicate around potential risks and benefits related to treatment decision making in parents/adult caregivers of children with medical complexity. The objective of this study is to identify the most effective ways to communicate decision-related risks and benefits to improve the quality of caregiver decision making for children with medical complexity.

Participants will view a video of a simulated clinic visit and related medical information and complete a survey about their experiences. Researchers will compare participant survey responses to see if decision quality changes based on the information reviewed by the participant.

Conditions

  • Multiple Chronic Conditions
  • Children With Medical Complexity

Interventions

BEHAVIORAL

Ambiguity

The intervention is a novel communication approach to communicate ambiguity related to the potential risks and benefits associated with clinical decision making for parents and caregivers of children with medical complexity.

BEHAVIORAL

Complexity

The intervention is a novel communication approach to communicate complexity related to the potential risks and benefits associated with clinical decision making for parents and caregivers of children with medical complexity.

BEHAVIORAL

Normalizing language

The intervention is a novel communication approach to normalize and explain the inherent uncertainty faced by parents of children with medical complexity during clinical decision making.

BEHAVIORAL

Narrative

Parent and caregiver narratives about their decision making experiences for the care of their child with medical complexity.

Sponsors & Collaborators

Principal Investigators

  • Jody L Lin, MD, MS · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-29
Primary Completion
2024-08-29
Completion
2024-08-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05913206 on ClinicalTrials.gov